Introduction to Market Access in Norway
LMI are delighted to invite members and non-members to a full day of getting to know the Norwegian system for market access- from scratch. The event offers a step-by-step guide aiming to explain, unveil and uncover all the potential Norway-specific challenges to encounter when launching — or trying to launch — a product in Norway, and what to do when they arise. This all-day course is intended for both LMI members and non-members, natives, and non-Norwegian-natives and for employees in all company departments looking to learn more about how the Norwegian system for market access is designed, how the different system actors work and what is required when communicating and dealing with them.
Starting from the beginning, uniquely knowledgeable industry representatives and relevant system actors will guide participants through a program designed specifically for pharma industry representatives in general— not exclusively for market access employees.
Starting from when a product receives market approval, this day will cover all the significant steps and hurdles through the Norwegian system until the product is eventually approved for reimbursement and given to Norwegian patients.
Hosted at the modern and centrally located Thon Hotel Opera and with English as the main language of the day, course participants will encounter fellow industry representatives and enjoy a day of knowledge-building and competence sharing through interactive activities, Q&A sessions, and informative lectures.
The official program is yet to be announced, but please save the date, or register already now to reserve a seat. Please note that registrations are binding. This course is limited to 72 spaces available on a first come first serve basis.
Please contact Didrik Ottesen (email@example.com) or Karoline Knutsen (firstname.lastname@example.org) if you have any queries.
Place: Thon Hotel Opera, Oslo
Price: NOK 5900 for members NOK 9900 non-members